Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.70 |
| ▸ | CRHBP | P24387 | 2/20 | 0.70 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | ATM | Q13315 | 1/20 | 0.70 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.50 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.50 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28468333 | 0.86 | ACHE (0.64) | ALDH1A1L3MBTL1CRHBPCRHR2MEN1 | |
| SCHEMBL1468921 | 0.85 | CYP1A2 (0.56) | ALDH1A1L3MBTL1CRHBPCRHR2MEN1 | |
| SCHEMBL27877152 | 0.83 | POLB (0.53) | ALDH1A1L3MBTL1CRHBPCRHR2MEN1 | |
| SCHEMBL1039452 | 0.83 | ALDH1A1 (1.00) | ALDH1A1L3MBTL1CRHBPCRHR2MEN1 | |
| SCHEMBL17817838 | 0.83 | ALDH1A1 (1.00) | ALDH1A1L3MBTL1CRHBPCRHR2MEN1 | |
| SCHEMBL3853529 | 0.83 | ALDH1A1 (1.00) | ALDH1A1L3MBTL1CRHBPCRHR2MEN1 | |
| SCHEMBL5842100 | 0.81 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1CRHBPCRHR2MEN1 | |
| SCHEMBL5843018 | 0.81 | CRHBP (0.64) | ALDH1A1L3MBTL1CRHBPCRHR2MEN1 | |
| SCHEMBL27732618 | 0.81 | ALDH1A1 (0.96) | ALDH1A1L3MBTL1CRHBPCRHR2MEN1 | |
| SCHEMBL7149333 | 0.80 | NR3C2 (0.60) | ALDH1A1L3MBTL1CRHBPCRHR2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111732516-B | A kind ofNProcess for preparing (E) -aryl-substituted heterocyclic compounds | 南昌大学 | 2021-01-05 | — | — | CN | disclosed |
| CN-111732516-A | A kind ofNProcess for preparing (E) -aryl-substituted heterocyclic compounds | 南昌大学 | 2020-10-02 | — | — | CN | disclosed |
| US-7067549-B2 | Pyrrolidone carboxamides | ACTELION PHARMACEUTICALS AG (CH) | 2006-06-27 | — | — | US | disclosed |
| US-20050192292-A1 | Pyrrolidone carboxamides | ACTELION PHARMACEUTICALS AG (CH) | 2005-09-01 | — | — | US | disclosed |
| EP-1463724-A1 | PYRROLIDONE CARBOXAMIDES | Actelion Pharmaceuticals Ltd. (CH) | 2004-10-06 | — | — | EP | disclosed |
| WO-2003059905-A1 | PYRROLIDONE CARBOXAMIDES | ACTELION PHARMACEUTICALS LTD (CH) | 2003-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192292-A1 | Pyrrolidone carboxamides | NPY1R, NPY5R, NPY2R | ALDH1A1 3034/4885L3MBTL1 3047/4885CRHBP 312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.